Indian multinational pharmaceutical company Lupin has launched a generic cholesterol-lowering tablets in the US market.
The company has launched Atorvastatin Calcium tablets in the strengths of 10, 20, 40, and 80 milligrams, having received an approval earlier from the US Food and Drug Administration (USFDA), the drug company said in a statement on Monday (September 28).
The product will be manufactured at the company’s site located in the western Indian city of Nagpur, it added.
The tablets are generic versions of Pfizer Inc’s Lipitor tablets in the same strengths, Lupin said.
Atorvastatin is indicated to lower cholesterol in blood for adults and children over 10 years of age.
It is also prescribed to lower the risk of heart attack and stroke in patients with cardiovascular diseases, diabetes and other risk factors such as eye problems, kidney diseases or high blood pressure, the drug firm added.
According to IQVIA moving annual total July 2020 data, Atorvastatin Calcium tablets USP had annual sales of approximately £435 million in the US, the Mumbai-based firm said.
